PDA

View Full Version : Dissolution Discussion


Pages : 1 2 [3] 4 5 6 7 8 9

  1. Er, Sr, Od Dosage Forms
  2. Temperature of bath
  3. Dissolution Of Suspension
  4. Filters
  5. MR Specifications
  6. precipitation probleam in phosphate buffer
  7. f2 comparisons
  8. slowing down a profile...
  9. Dissolution Of Combination Drug Product
  10. Low volume vessels for apparatus 2
  11. volume of dissolution media
  12. Acceptance Criteria
  13. Surfactants in Automation?
  14. How to handle scratched vessels
  15. dissolution problem with micronized drug
  16. dissolution problem
  17. Selection of Dissolution Media
  18. Calibration of Apparatus 3
  19. Phosphate at pH 4.5
  20. How does the work get done?
  21. Prednisone Calibrator Failures
  22. New Bulletin Board
  23. why 6 tabs for disso
  24. Isotonic Solution
  25. %RSD Problem of sticky ref. std
  26. Media for Immediate Release dosage
  27. Prednisone Baskets failing results (Low numbers)
  28. dissolution of oral suspensions
  29. Use of Sinkers for Capsules
  30. Dissolution Testing Time Point
  31. Prednisone Lot O0C056
  32. Coating Questions
  33. Dissolution testing market?
  34. USP apparatus 7
  35. Simvastatin stability and dissolution
  36. gliclazide
  37. miglitol
  38. dissolution medium for transdermal patch
  39. Dissolution Medium
  40. patch
  41. basket calibration
  42. Prednisone Calibration Failure
  43. broken vessels
  44. % drug dissolved
  45. pKa
  46. Media preparation
  47. Dissolution comparison
  48. How to Start New Threads
  49. dialysis membranes in apparatus 3
  50. water activity
  51. Acid resistance of enteric coated pellets
  52. Shaft Wobble
  53. dissolution for nanoparticulate formulations
  54. Timeframe for Dissolution
  55. Solubility of Pioglitazone hydrochloride
  56. Discriminating Dissolution
  57. starchy affair
  58. dr media for loratidine
  59. Ways of getting low density granules
  60. Dissolution medium for softgel containing phosphatidylcholine i.e. Lecithin?
  61. Help with problem
  62. Disso Method Validation
  63. Acid resistance of Enteric coated pellets
  64. Apparatus III Questions
  65. Dissolution Medium Waste Disposal
  66. Supac-mr
  67. nateglinide dissolution
  68. cone effect
  69. Dissolution Flask Uniformity
  70. prednisone calibration
  71. Dissolution method specification
  72. Buspirone Hydrochloride
  73. Loratidine Tablet Dissoolution
  74. dissolution profile decrease after 100%
  75. Interesting situation
  76. USP Apparatus 4/Dissolution Medium
  77. Spectral shifts
  78. Validation of Dissolution Tester
  79. filters
  80. high results with calibrator tablets
  81. dissolution of poorely soluble drug
  82. F2 Calculations HELP PLEASE
  83. Why poly(vinyl alcohol) is soluble in toluene?
  84. Water vs Phosphate Buffer pH 6,8
  85. Rice paper boxes....?
  86. Guidelines and their violations
  87. USP Requests Opinion About Dissolution Standards for Fat-Soluble Vitamins
  88. Enalapril maleate. As per USP DR
  89. Component validation
  90. Basis for selecting index vitamins and elements
  91. Dissolution medium
  92. Rotating baskets with fins
  93. polyox dissolutions
  94. disso volumes
  95. Autosampler Timer Calibration
  96. discriminatory media
  97. Flow through cells. Calculations?
  98. Fenofibrate Dissolution
  99. Dissolution Buffer
  100. deaeration for Apparatus III
  101. Fed/ Fasting SSIF
  102. Disso. Specifications
  103. Validation acid stage
  104. Product insoluble in aqous Media
  105. Combinaton of surfactant
  106. Dissolution Profile Comparision
  107. Number of Standard Reads
  108. Concentrates
  109. Media Discrimination
  110. alternative testing method of HCTZ - Irbesartane combination
  111. Dissolution Method Validation -stability
  112. Disso Standard Prep in HPLC
  113. Calibration
  114. Poll: UV-Vis Detection: Fiber Optic vs Transfer
  115. Data analysis environment
  116. Dissolution profile FOR FED and Faseted SIF media
  117. losartan dissolution
  118. Dissolution drugs unstable in aqueous media
  119. Erroneous dissolution profile
  120. Effect of change in pH on absorbance
  121. Dissolution medium for BE study
  122. Injectible suspensions
  123. Uncertainty
  124. dissolution profile sampling
  125. DDG Registration and Posting Guidelines
  126. dissolution method validation
  127. Different f2 and release rates in different pH buffers
  128. hydroalcoholic media
  129. Dissolution reference needed.
  130. two tier dissolution for capsules
  131. which lmax to be used
  132. dissolution of glucose
  133. deagassing nano-LC colomns
  134. pyrimethamine+sulfadoxine combination
  135. f1 ,f2 for FDC Dosage Forms
  136. price f average BE study ?
  137. Albendazole
  138. surfactants in dissolution media
  139. decrease in dissolution
  140. dissolution and shelf life
  141. ph range for dissoultion medium
  142. Compression force used to make pellet for Intrinsic Dissolution Rate
  143. validation of dissolution method for sustained release capsules
  144. Dissolution parameters
  145. DR - more than 100%
  146. Dilution of dissolution samples
  147. sampling point for 800 ml and automation
  148. Sgf
  149. Dissolution testing of paste formulations
  150. Stagnant areas - high variability
  151. high uv absorbance values
  152. Melt tablets
  153. glucose forms a bloc, why?
  154. Decreasse the CV in the dissolution test
  155. influence of placebo
  156. Dissolution Autosampler comparison
  157. captopril dissolution
  158. Air bubble formation
  159. USP Acceptance of Different Basket Attachments
  160. Surfactant(s) for water insoluble drugs
  161. Erythromycin Ethyl Scccinate - BE ???
  162. Help regarding ?N of HCl in SGF
  163. Comparison of analysis techniques
  164. Bench Stability
  165. Stability of solutions
  166. leflunomide tablets
  167. Rotating flask
  168. Replacing dissolution machine with shaker incubator for in-vitro digestion.
  169. Regarding dissolution of fruit samples
  170. rapidly dissolving drug?
  171. The purchase of surfactant
  172. solubility of flavonoids
  173. Proposed General Chapter
  174. Dissolution Testing & Bioequivalence Of Sildenafil Citrate Tablets
  175. DL/QL determination for UV/VIS method
  176. Extraction from formulations
  177. f2 Factor
  178. Dissolution medium for celecoxib
  179. UV Quantitation approach: Up front vs bracketing vs grand average
  180. Bad result of innovator tablets?
  181. %RSD between individual dissolution samples
  182. Dissolution of Depot formulation
  183. Drug release from microspheres depot formulations
  184. Dissolution medium of Lomefloxacin HCl
  185. Dissolution medium of Repaglinide Tablets
  186. Over Encapsulated Capsules
  187. Placebo Effect
  188. Dissolution as bioequivalence tool
  189. dissolution of NaCl and Sodiumbicarbonat
  190. AAPS Workshop Recap
  191. Olenzapine Dissolution
  192. Dissolution of Ir metal?
  193. Dissolution of sparingly water soluble drug
  194. How we should assign a 'Q'Value for Non Pharmacoepial product
  195. mini vessels
  196. Dissolution profile Nimesulide
  197. Optium Particle Size
  198. Detection method?
  199. What do you do to keep dissolution apparatus clean.
  200. Paddles in motion
  201. weak base drug
  202. ********-spindle vs Metal-strip
  203. saturation solubility
  204. ICH Harmonization
  205. sticking of controlled release tablets
  206. What is the Procedure to study the Release Pattern of Liposomes
  207. Effect of solvent used to preapare a standard solution
  208. dissolution method for dry suspensions
  209. BP Acceptance Level
  210. open loop or media replacement?
  211. Oral Suspensions: Dosing Introduction Technique
  212. METFORMIN HCL DISSOLUTION IN pH 2.1 SGF
  213. Distance between agitator end to bottom of flask.
  214. Measurement of SLS containing medium
  215. invitro removal of permeability of a drug
  216. methscopolomine nitrate
  217. Dissolution bath vessel replacement
  218. SDS precipitate with chilling
  219. Acenocoumarol tablets
  220. Parameters to make sure a bio-equivalent product is prepared.
  221. Non compendial product
  222. pka determinations
  223. Extended Release dissolution testing
  224. reduced volume (200 mL) vessels
  225. Azithromycin suspension
  226. Glimepiride
  227. Herbal Tablet Dissolution
  228. omeprazole
  229. dissolution of oily suspension for IM injection
  230. dissolution calibration
  231. zidovudine
  232. Hydrochlorothiazide
  233. Dissolution profile
  234. System to System Variation
  235. paddle speed?
  236. Dissolution medium of Montelukast Na
  237. Dissolution media for Tadalafil
  238. Dissolution Method for Oily formulations / Microemulsions
  239. methods for water insoluble drugs
  240. Dissolution validation
  241. Crosslinking and assay issues (m)
  242. Prednisone Calibrators
  243. stability indicating method
  244. Discriminating profile
  245. pH 3 buffer
  246. Method development
  247. Tablet position in the basket
  248. Surfactant CMC
  249. Buffer Ionic Strength
  250. Using vessel 7 + 8 to increase efficiency